IP Library Granted Patent US 11,185,492
Granted Patent B2
US 11,185,492 · App. 16/706,290 · Granted Nov 30, 2021

Cosmetic compositions

Inventors: Tiffany Carle (Addison, TX); Milagros Sanchez (Addison, TX); David Gan (Addison, TX)
Assignee: MARY KAY INC.
A61K8/9789A61K8/06A61K8/11A61K8/676A61K8/678A61Q19/007A61Q19/08A61K8/44A61K2800/412A61K2800/413
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,185,492
App. No.
16/706,290
Granted
Nov 30, 2021
Kind
B2
Abstract

Disclosed are compositions and methods for their use for cosmetic applications. The composition can include tetrahexyldecyl ascorbate, Phyllanthus emblica fruit extract, and tocopherol, ascorbic acid. The composition can further include vegetable amino acids. An effective amount of the composition can be applied on skin to stimulate collagen production and lysyl oxidase activity, inhibit tyrosinase, inhibit melanogenesis and/or COX-1 activity, and inhibit the matrix metalloproteinase enzyme activity in skin.

Claims (27)

1. A method of improving a condition or appearance of skin comprising applying to the skin an effective amount of a topical skin composition comprising tetrahexyldecyl ascorbate, Phyllanthus emblica fruit extract, ascorbic acid, and optionally tocopherol.

2. The method of claim 1 , wherein the topical skin composition further comprises vegetable amino acids.

3. The method of claim 2 , wherein, by applying the topical skin composition, the skin is treated to inhibit melanogenesis, tyrosinase, or both.

4. The method of claim 1 , wherein the ascorbic acid, tocopherol, or both are encapsulated in microspheres, nanospheres, or both configured for controlled release of ascorbic acid and tocopherol to the skin.

5. The method of claim 4 , wherein the ascorbic acid is encapsulated in nanospheres and tocopherol is encapsulated in microspheres.

6. The method of claim 5 , wherein the nanospheres encapsulating the ascorbic acid are surrounded by microspheres encapsulating the tocopherol.

7. The method of claim 4 , wherein the ascorbic acid and tocopherol are encapsulated such that one or more ascorbic acid particles are disposed as a core portion that is encapsulated by a microsphere containing tocopherol.

8. The method of claim 1 , wherein, by applying the topical skin composition, the skin is treated to:

improve a skin condition comprising skin radiance, skin tone clarity, skin brightness, skin tone evenness, or any combination thereof;

to reduce a skin condition comprising photo damage, loss of facial firmness, fine lines, deep lines, wrinkles, skin dullness, skin sagging, appearance of age spots on skin, or any combination thereof;

to increase moisture level of the skin; or

any combination thereof.

9. The method of claim 8 , wherein, by applying the topical skin composition, the skin moisture level is increased within about 15 minutes of applying the topical skin composition.

10. The method of claim 1 , wherein, by applying the topical skin composition, the skin is treated to;

inhibit matrix metalloproteinase enzyme activity;

to stimulate production of matrix proteins that comprise collagen, lysyl oxidase, or both;

to inhibit production of cyclooxygenase-1; or

any combination thereof.

11. The method of claim 10 , wherein the matrix metalloproteinase enzyme includes MMP3.

12. The method of claim 1 , wherein the Phyllanthus emblica fruit extract is an aqueous extract from Phyllanthus emblica fruit.

13. The method of claim 1 , wherein the topical skin composition is a polymeric emulsion.

14. The method of claim 1 , wherein the topical skin composition is applied to a fine line, a wrinkle, an age spot, a deep line on the skin, sagging skin, non-elastic skin, or any combination thereof.

15. The method of claim 1 , wherein the topical skin composition is applied to facial skin including the periorbital region of the skin, the crow's feet region of the skin, neck skin, or any combination thereof.

16. The method of claim 1 , wherein, after topical application, the topical skin composition remains on the skin for at least 30 minutes.

17. The method of claim 1 , wherein the topical skin composition is applied one or more times daily for at least 4 weeks.

18. The method of claim 1 , wherein the topical skin composition comprises an effective amount of tetrahexyldecyl ascorbate, and/or Phyllanthus emblica fruit extract to stimulate production of collagen.

19. The method of claim 1 , wherein the ascorbic acid and/or tocopherol are encapsulated.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 068354/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2019
From: CARLE, TIFFANY; SANCHEZ, MILAGROS; GAN, DAVID
To: MARY KAY INC.
Reel/Frame 051206/0923 →
Continuity (2)
Provisional Application 62780036 · Dec 14, 2018
Related Publication 20200188292A1 · Jun 18, 2020